Sarepta Therapeutics
SRPT
#2549
Rank
โ‚ฌ4.58 B
Marketcap
47,29ย โ‚ฌ
Share price
-0.28%
Change (1 day)
-57.20%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): โ‚ฌ0.24 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ1.90 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ0.46 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ0.22 B-150.14%
2023 -โ‚ฌ0.46 Billion-24.62%
2022 -โ‚ฌ0.61 Billion64.69%
2021 -โ‚ฌ0.37 Billion-24.25%
2020 -โ‚ฌ0.49 Billion-22.53%
2019 -โ‚ฌ0.63 Billion96.87%
2018 -โ‚ฌ0.32 Billion645.68%
2017 -โ‚ฌ42.75 Million-81.81%
2016 -โ‚ฌ0.24 Billion21.47%
2015 -โ‚ฌ0.2 Billion62.04%
2014 -โ‚ฌ0.12 Billion21.26%
2013 -โ‚ฌ98.45 Million60.93%
2012 -โ‚ฌ61.18 Million93.69%
2011 -โ‚ฌ31.59 Million71.58%
2010 -โ‚ฌ18.41 Million35.06%
2009 -โ‚ฌ13.63 Million-11.62%
2008 -โ‚ฌ15.43 Million-47.02%
2007 -โ‚ฌ29.11 Million0.38%
2006 -โ‚ฌ29 Million88.3%
2005 -โ‚ฌ15.4 Million-30.06%
2004 -โ‚ฌ22.02 Million32.69%
2003 -โ‚ฌ16.6 Million-25.52%
2002 -โ‚ฌ22.28 Million64.52%
2001 -โ‚ฌ13.55 Million50.4%
2000 -โ‚ฌ9.01 Million26.44%
1999 -โ‚ฌ7.13 Million8%
1998 -โ‚ฌ6.6 Million102.7%
1997 -โ‚ฌ3.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ0.60 B 164.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.14 Billion-160.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.29 Billion-223.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ76.45 Million-133.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.21 Billion-190.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.32 Billion-239.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.73 Billion-418.21%๐Ÿ‡บ๐Ÿ‡ธ USA